ArticleTherapeutic advances in infectious disease

Prevalence and determinants of dolutegravir resistance among people living with HIV with virologic failure in North-Eastern Uganda: a retrospective cross-sectional study (2022-2024).

Saadick Mugerwa Ssentongo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.